DeepDx Prostate is a clinically validated and CE marked AI diagnostic support software for prostate cancer. The software analyzes digitized slide images of Hematoxylin & Eosin (H&E) stained prostate specimens to detect and localize areas of interest. These areas of interest are detected based on their severity in accordance with the Gleason Scoring System. Currently DeepDx Prostate is used for research purpose only, but its FDA approval is in progress.
3 Specimen Types
Needle biopsy, TURP, Prostatectomy
500k+ cores analyzed
We bring value into your workflow
01Clinical Outputs that Guide Therapy
Length measurement and Gleason scores can be generated automatically.
02Fast and Accurate
It takes 30 seconds to run the AI analysis (per core), and improves accuracy with 99% sensitivity and 94% specificity.
DeepDx Prostate has been tested in US population. Its validation studies were published in prestigious peer reviewed medical journals including Cancers and npj Digital Medicine
DeepDx Prostate generates consistent results allowing higher reproducibility in diagnoses
DeepDx Prostate key functions
DeepDx Prostate highlights the cancerous lesions of the Gleason pattern 3, 4, and 5 and generates 3 different colored overlays on the slide images.
Tumor & Pattern Quantification
The proportions of each Gleason pattern out of the total tumor area and tumor-to-tissue ratios are automatically quantified.
Quantitative metrics such as tumor-to-tissue ratios and Gleason pattern ratios are recalculated real-time as annotations are made.
Annotation tool allows the user to draw or revise the AI results. Automatic measurements of total tissue and total tumor lengths are also generated.
I can instantly check the results from DeepDx Prostate with a simple click of a button- sometimes revealing small areas of concern that I would have missed had I not had the tool running in the background.
Min-Sun Jin, MD
MD, Bucheon St.Mary’s Hospital
In particular, it (DeepDx Prostate) reduces inter-and intra-observer variability. In hospitals without pathology residents, using DeepDx Prostate for screening will allow pathologists to spend more time and energy on their research
MD, StarPath Founder
This tool is very helpful for quality assurance in that it enables the pathologist to re-look at areas that they did not annotate originally, but that the AI algorithm did, and determine if there are additional areas of interest that require their attention
DeepDx Prostate can be used in a variety of use settingsincluding first read, concurrent read, quality control,and research and development.